Couldn't load this record
Something went wrong loading this record — please try again.
Patent Application
Utility
App. No. 16/702,322
· Confirmation No. 6713
ENHANCED BIOAVAILABILITY OF N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)-PHENYL)CYCLOPENTYL)METHYL)UREA HYDROCHLORIDE
Inventor:
Pharis Mohideen
Applicant:
Millendo Therapeutics, Inc.
Abandoned -- Incomplete Application (Pre-examination)
No downloadable documents found — record may not be publicly available.
Inventors
Pharis Mohideen
Pine Brook, NJ
Attorneys & Agents of Record
Classification
USPC
514/312
Prosecution
- Art Unit
- 1629
- Customer No.
- 500
- Docket No.
- 120205.409C1
- Confirmation No.
- 6713
Parent
is a Continuation of
→
App. 15/743,418
Filed 2018-01-10
· Abandoned -- Failure to Respond to an Office Action
Parent
PCT
is a National Stage Entry of
→
PCT/US2016/041501
Filed 2016-07-08
· Abandoned -- Incomplete Application (Pre-examination)
Parent
Claims priority from a provisional application
→
App. 62/191,195
Filed 2015-07-10
· Provisional Application Expired
Child
is a Continuation of
→
App. 17/191,556
Filed 2021-03-03
· Abandoned -- Incomplete Application (Pre-examination)
Child
is a Continuation of
→
App. 17/514,538
Filed 2021-10-29
· Abandoned -- Failure to Respond to an Office Action
Child
is a Continuation of
→
App. 16/936,279
Filed 2020-07-22
· Abandoned -- Incomplete Application (Pre-examination)
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/702,322
- Filed
- 2019-12-03
- Art Unit
- 1629
External Links